Serial structural MRI analysis and proton and 31PMR spectroscopy in the investigation of cerebral fatty acids in major depressive disorder, Huntington's disease, myalgic encephalomyelitis and in forensic schizophrenic patients.
Puri
Basant K
BK
Tsaluchidu
Sofia
S
Treasaden
Ian H
IH
D001923:Brain Chemistry; D001927:Brain Diseases / Q000378:metabolism*; D003865:Major Depressive Disorder / Q000188:drug therapy / Q000378:metabolism; D004032:Diet; D015118:Eicosapentaenoic Acid / Q000008:administration & dosage; D015673:Fatigue Syndrome, Chronic / Q000188:drug therapy / Q000378:metabolism; D005227:Fatty Acids / Q000032:analysis*; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage; D005554:Forensic Medicine; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy / Q000378:metabolism; D008279:Magnetic Resonance Imaging / Q000379:methods; D009682:Magnetic Resonance Spectroscopy / Q000379:methods; D001523:Mental Disorders / Q000378:metabolism*; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism
D005227:Fatty Acids; D015525:Fatty Acids, Omega-3; D015118:Eicosapentaenoic Acid